SET, an endogenous inhibitor of protein phosphatase 2A, was overexpressed in all subtypes of invasive breast carcinoma tissues. Treatment with SET-targeted siRNAs reduced the motility of MCF-7 and MDA-MB-231 cells in transwell assay.
[Scientific Reports]
7992332
{7992332:WZ8X64K3}
apa
50
1
164397
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
